Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Clinical Review Report: Baricitinib (Olumiant): (Eli Lilly Canada Inc
3-H)propyl][2-(thiophen-2-yl)ethyl]amino}-5
CAS Number: 599-79-1
and is approximately 135-fold more potent than imatinib for inhibiting the PDGFRA D842V mutation
PLC/PRF/5，HA22T/VGH and Huh7 cells
Sofosbuvir impurity D Catalog No.:M15270-2 Clinical Review Report: Baricitinib (Olumiant):Sofosbuvir impurity D is an impurity of Sofosbuvir, Sofosbuvir is an active inhibitor of HCV RNA replication in the HCV replicon assay, demonstrates potent anti hepatitis C virus (HCV) activity. Product information Molecular Weight: 529. 45 Formula: C22H29FN3O9P Chemical Name: propan 2 yl (2S) 2 {[(S) {[(2S,3S,4S,5S) 5 (2,4 dioxo 1,2,3,4 tetrahydropyrimidin 1 yl) 4 fluoro 3 hydroxy 4 methyloxolan 2 yl]methoxy}(phenoxy)phosphoryl]amino}propanoate
US$ 172.69
US$ 160.00
US$ 277.55
US$ 388.44